[DNLI] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
04-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -39.37%
YoY- -45.27%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 52,480 42,141 12,514 5,285 22,939 7,923 316,815 -69.93%
PBT -58,767 -65,220 -75,836 -84,588 -60,691 -70,041 245,708 -
Tax 27 -1,278 -575 782 728 -2,108 823 -89.81%
NP -58,794 -63,942 -75,261 -84,588 -60,691 -70,041 244,885 -
Tax Rate - - - - - - -0.33% -
Total Cost 111,274 106,083 87,775 89,873 83,630 77,964 71,930 33.86%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -112.03 -151.73 -601.41 -1,600.53 -264.58 -884.02 77.30 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.48 -0.52 -0.62 -0.69 -0.50 -0.58 2.04 -
EPS Diluted -0.48 -0.52 -0.62 -0.69 -0.49 -0.58 1.91 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.